给 医 护 专 业 人 员 的 信   Clobazam-containing products: Assessing the Potential Risk of Drug Reaction with Eosinophilia and Systemic Symptoms (Letter to Healthcare Professionals) (English only)       附件: Clobazam-containing products: Assessing the Potential Risk of Drug Reaction with Eosinophilia and Systemic Symptoms (English only)   Related Information: The United States: FDA warns of rare but serious drug reaction to the antiseizur... 上载于 2023-11-29 FDA warns of rare but serious drug reaction to the antiseizure medicines levetir... 上载于 2023-11-29 Canada: Summary Safety Review: Clobazam-containing products: Assessing the poten... 上载于 2020-12-10